Creative Planning’s Bionano Genomics BNGO Stock Holding History

Creative Planning’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-28	Closed	-$23K	–	2331
2022 Q2	$23K	Buy	+28	New	+$28.8K	﹤0.01%	2124
2021 Q2	–	Sell	-99	Closed	-$478K	–	2132
2021 Q1	$478K	Buy	99 +24	+32%	+$135K	﹤0.01%	1474
2020 Q4	$139K	Buy	+75	New	+$28K	﹤0.01%	1973

Other funds holding BNGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Creative Planning's BNGO Position: Q3 2022 in Review

Creative Planning sold out of Bionano Genomics (BNGO) in Q3 2022, closing a stake of 28 shares — an estimated $23K sold.

Creative Planning first reported a position in BNGO in Q4 2020 and held it in 3 quarters. The position peaked at $478K in Q1 2021. 140 funds tracked by Wall St. Rank hold BNGO as of Q3 2022.

Creative Planning reported no remaining Bionano Genomics position as of Q3 2022 after selling out during the quarter.
Creative Planning sold 28 Bionano Genomics shares in Q3 2022, an estimated $23K.
Creative Planning first reported a position in Bionano Genomics in Q4 2020 and held it in 3 quarters.
Creative Planning's Bionano Genomics position peaked at $478K in Q1 2021.
140 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2022.

Based on Creative Planning's 13F filing for Q3 2022, filed 3 Nov 2022.